Characterization and prognostic implication of delayed complete response in AL amyloidosis

INTRODUCTION: Little is known on continued response following completion of therapy in light chain (AL) amyloidosis. METHODS: We studied 373 AL amyloidosis patients who achieved complete response (CR) or very good partial response (VGPR) to first-line therapy. RESULTS: By end of therapy (EOT), 46% o...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Eur J Haematol
Auteurs principaux: Muchtar, Eli, Gertz, Morie A., Kumar, Shaji K., Lacy, Martha Q., Leung, Nelson, Buadi, Francis K., Dingli, David, Hayman, Suzanne R., Go, Ronald S., Kapoor, Prashant, Gonsalves, Wilson, Kourelis, Taxiarchis V., Warsame, Rahma, Hwa, Yi Lisa, Fonder, Amie, Hobbs, Miriam, Russell, Stephen, Lust, John A., Siddiqui, Mustaqueem, Rajkumar, S. Vincent, Kyle, Robert A., Dispenzieri, Angela
Format: Artigo
Langue:Inglês
Publié: 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8103541/
https://ncbi.nlm.nih.gov/pubmed/33230879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ejh.13554
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires